The new offerings, ZenTite and Density, aim to improve skin resilience and contouring without the need for invasive surgery or lengthy recovery periods. By integrating these technologies into their existing portfolio, the company targets specific demographic shifts in the beauty market where patients increasingly prioritize non-invasive maintenance over traditional procedures.

Clint Carnell, founder and CEO of OrangeTwist, stated that the move reflects a broader push to redefine the capabilities of modern skin-tightening. Since its inception in 2015, the brand has operated under a model of medically supervised care, currently spanning six states. These treatments are available immediately for clients seeking alternatives to surgical intervention for laxity and texture issues.